Pipeline

mCRPC / Abiraterone

Enrolling

mPDAC / Biomarker

Target Q1 '22

CMML / Single Agent

Development

Medulloblastoma / Combo w/ radiation

Development

Ovarian / PARP inhibitors

Development

Looking to partner with us?

Please send inquiries to [email protected]